Table 1.
AMD Human Donor Additional Information
| Donor ID | Age* | Sex | Race | D-to-P† | Ocular History‡ |
|---|---|---|---|---|---|
| 1 | 90 | M | C | 16 | Neovascular AMD |
| 2 | 87 | F | C | 5 | Nonneovascular AMD |
| 3 | 95 | F | C | 7 | AMD |
| 4 | 94 | M | C | 6 | AMD |
| 5 | 96 | F | C | 9 | AMD |
| 6 | 91 | F | C | 15 | AMD |
| 7 | 90 | F | C | 15 | AMD |
| 8 | 87 | M | C | 12 | Nonneovascular AMD |
| 9 | 94 | F | C | 21 | AMD |
| 10 | 87 | F | C | 11 | AMD |
| 11 | 87 | F | C | 33 | Nonneovascular AMD |
| 12 | 97 | F | C | 5 | Neovascular AMD |
| 13 | 86 | F | C | 23 | Neovascular (exudative)§ AMD |
| 14 | 86 | F | C | 9.4 | AMD (neovascular & nonneovascular ) |
| 15 | 85 | F | C | 8 | AMD (neovascular – exudative - ODǁ & nonneovascular) |
| 16 | 89 | F | C | 9 | AMD |
| 17 | 65 | M | C | 18.5 | AMD |
| C1 | 92 | M | C | 11 | None |
| C2 | 84 | F | C | 10 | None |
| C3 | 66 | F | C | 6 | None |
| C4 | 72 | M | C | 5.8 | None |
| C5 | 91 | M | C | 8 | None |
| C6 | 95 | F | C | 4 | None |
| C7 | 57 | F | C | 13 | None |
| C8 | 78 | M | C | 4.5 | None |
| C9 | 66 | F | C | 8 | None |
| C10 | 71 | F | C | 7 | None |
M, male; F, female; C, Caucasian.
*
Age at death (years).
†
Interval from death to preservation (hours).
‡
Ocular Disease Classification according to both eye bank records and fundus imaging.
§
Donor was treated with Avastin for three years according to the eye bank record.
ǁ
Eye bank record indicated that donor received “injections” in the right eye.